RENOVORX, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RENOVORX, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $9.00K, a 25.00% decline year-over-year.
- RENOVORX, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $8.00K, a 80.95% decline year-over-year.
- RENOVORX, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $15.00K.
- RENOVORX, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $12.00K, a 500.00% increase year-over-year.
- RENOVORX, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $17.00K, a 75.36% decline from fiscal 2024.
- RENOVORX, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $69.00K, a 762.50% increase from fiscal 2023.
- RENOVORX, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $8.00K, a 80.95% decline from fiscal 2022.
- RENOVORX, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $42.00K, a 60.75% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $17.00K 10-K · filed 2026-03-30 | |
| 2025-06-30 | $9.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $8.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $69.00K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $15.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $12.00K 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $42.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $8.00K 10-K · filed 2025-04-01 | |
| 2023-06-30 | $2.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $6.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $42.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $4.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $9.00K 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $26.00K 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $107.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $51.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $5.00K 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $34.00K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $18.00K 10-K · filed 2022-03-30 | |
| 2020-03-31 | $11.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |